Amgen Fell 4% Last Week. Here’s Where the Stock Could Head in 2026
Amgen Inc. stock saw a 4% decline last week following its Q4 earnings release, despite beating revenue and adjusted EPS estimates. This dip was largely attributed to investors cashing in gains after a strong run, as the positive earnings report did not significantly raise future expectations. Industry analysts offered mixed reactions, leading to various price target adjustments, while institutional investors showed mixed conviction with some increasing stakes and others trimming holdings.
https://www.tikr.com/blog/amgen-fell-4-last-week-heres-where-the-stock-could-head-in-2026?